Acceptance of nicotine dependence treatment among currently depressed smokers

Nancy A. Haug, Sharon M. Hall, Judith J. Prochaska, Amy B. Rosen, Janice Y. Tsoh, Gary Humfleet, Kevin Delucchi, Joseph S. Rossi, Colleen A. Redding, Stuart Eisendrath

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This study reports on baseline characteristics associated with acceptance and refusal of available smoking treatment among currently depressed smokers in a psychiatric outpatient clinic who were enrolled in a larger clinical trial. The sample (N=154) was 68% female and 72% White, with a mean age of 41.4 years and average smoking rate of 17 cigarettes/day. All participants were assigned to a repeated contact experimental condition; received a stage-based expert system program to facilitate treatment acceptance; and were then offered smoking treatment, consisting of behavioral counseling, nicotine patch, and bupropion. Acceptors (n=53) were defined as those accepting behavioral counseling and pharmacological treatment at some point during the 18-month study, whereas refusers (n=101) received only the expert system. The number of days to treatment acceptance was significantly predicted by stage of change, with those in preparation entering treatment more quickly than contemplators or precontemplators. In a logistic regression, the variables most strongly associated with accepting treatment were current use of psychiatric medication and perceived success for quitting. Severity of depressive symptoms, duration of depression history, and history of recurrent depression were not related to treatment acceptance. Findings have implications for the psychiatric assessment and treatment of smokers in clinical settings. Psychiatric medication may play a significant role in smoking cessation treatment acceptance by currently depressed smokers.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalNicotine and Tobacco Research
Volume7
Issue number2
DOIs
StatePublished - Apr 2005

Fingerprint

Tobacco Use Disorder
Psychiatry
Expert Systems
Therapeutics
Smoking
Depression
Counseling
Tobacco Use Cessation Products
Bupropion
Withholding Treatment
Smoking Cessation
Ambulatory Care Facilities
Tobacco Products
Logistic Models
Clinical Trials
Pharmacology

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Haug, N. A., Hall, S. M., Prochaska, J. J., Rosen, A. B., Tsoh, J. Y., Humfleet, G., ... Eisendrath, S. (2005). Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine and Tobacco Research, 7(2), 217-224. https://doi.org/10.1080/14622200500055368

Acceptance of nicotine dependence treatment among currently depressed smokers. / Haug, Nancy A.; Hall, Sharon M.; Prochaska, Judith J.; Rosen, Amy B.; Tsoh, Janice Y.; Humfleet, Gary; Delucchi, Kevin; Rossi, Joseph S.; Redding, Colleen A.; Eisendrath, Stuart.

In: Nicotine and Tobacco Research, Vol. 7, No. 2, 04.2005, p. 217-224.

Research output: Contribution to journalArticle

Haug, NA, Hall, SM, Prochaska, JJ, Rosen, AB, Tsoh, JY, Humfleet, G, Delucchi, K, Rossi, JS, Redding, CA & Eisendrath, S 2005, 'Acceptance of nicotine dependence treatment among currently depressed smokers', Nicotine and Tobacco Research, vol. 7, no. 2, pp. 217-224. https://doi.org/10.1080/14622200500055368
Haug, Nancy A. ; Hall, Sharon M. ; Prochaska, Judith J. ; Rosen, Amy B. ; Tsoh, Janice Y. ; Humfleet, Gary ; Delucchi, Kevin ; Rossi, Joseph S. ; Redding, Colleen A. ; Eisendrath, Stuart. / Acceptance of nicotine dependence treatment among currently depressed smokers. In: Nicotine and Tobacco Research. 2005 ; Vol. 7, No. 2. pp. 217-224.
@article{4a7972f2a4da47918d6f528caa23e15f,
title = "Acceptance of nicotine dependence treatment among currently depressed smokers",
abstract = "This study reports on baseline characteristics associated with acceptance and refusal of available smoking treatment among currently depressed smokers in a psychiatric outpatient clinic who were enrolled in a larger clinical trial. The sample (N=154) was 68{\%} female and 72{\%} White, with a mean age of 41.4 years and average smoking rate of 17 cigarettes/day. All participants were assigned to a repeated contact experimental condition; received a stage-based expert system program to facilitate treatment acceptance; and were then offered smoking treatment, consisting of behavioral counseling, nicotine patch, and bupropion. Acceptors (n=53) were defined as those accepting behavioral counseling and pharmacological treatment at some point during the 18-month study, whereas refusers (n=101) received only the expert system. The number of days to treatment acceptance was significantly predicted by stage of change, with those in preparation entering treatment more quickly than contemplators or precontemplators. In a logistic regression, the variables most strongly associated with accepting treatment were current use of psychiatric medication and perceived success for quitting. Severity of depressive symptoms, duration of depression history, and history of recurrent depression were not related to treatment acceptance. Findings have implications for the psychiatric assessment and treatment of smokers in clinical settings. Psychiatric medication may play a significant role in smoking cessation treatment acceptance by currently depressed smokers.",
author = "Haug, {Nancy A.} and Hall, {Sharon M.} and Prochaska, {Judith J.} and Rosen, {Amy B.} and Tsoh, {Janice Y.} and Gary Humfleet and Kevin Delucchi and Rossi, {Joseph S.} and Redding, {Colleen A.} and Stuart Eisendrath",
year = "2005",
month = "4",
doi = "10.1080/14622200500055368",
language = "English (US)",
volume = "7",
pages = "217--224",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Acceptance of nicotine dependence treatment among currently depressed smokers

AU - Haug, Nancy A.

AU - Hall, Sharon M.

AU - Prochaska, Judith J.

AU - Rosen, Amy B.

AU - Tsoh, Janice Y.

AU - Humfleet, Gary

AU - Delucchi, Kevin

AU - Rossi, Joseph S.

AU - Redding, Colleen A.

AU - Eisendrath, Stuart

PY - 2005/4

Y1 - 2005/4

N2 - This study reports on baseline characteristics associated with acceptance and refusal of available smoking treatment among currently depressed smokers in a psychiatric outpatient clinic who were enrolled in a larger clinical trial. The sample (N=154) was 68% female and 72% White, with a mean age of 41.4 years and average smoking rate of 17 cigarettes/day. All participants were assigned to a repeated contact experimental condition; received a stage-based expert system program to facilitate treatment acceptance; and were then offered smoking treatment, consisting of behavioral counseling, nicotine patch, and bupropion. Acceptors (n=53) were defined as those accepting behavioral counseling and pharmacological treatment at some point during the 18-month study, whereas refusers (n=101) received only the expert system. The number of days to treatment acceptance was significantly predicted by stage of change, with those in preparation entering treatment more quickly than contemplators or precontemplators. In a logistic regression, the variables most strongly associated with accepting treatment were current use of psychiatric medication and perceived success for quitting. Severity of depressive symptoms, duration of depression history, and history of recurrent depression were not related to treatment acceptance. Findings have implications for the psychiatric assessment and treatment of smokers in clinical settings. Psychiatric medication may play a significant role in smoking cessation treatment acceptance by currently depressed smokers.

AB - This study reports on baseline characteristics associated with acceptance and refusal of available smoking treatment among currently depressed smokers in a psychiatric outpatient clinic who were enrolled in a larger clinical trial. The sample (N=154) was 68% female and 72% White, with a mean age of 41.4 years and average smoking rate of 17 cigarettes/day. All participants were assigned to a repeated contact experimental condition; received a stage-based expert system program to facilitate treatment acceptance; and were then offered smoking treatment, consisting of behavioral counseling, nicotine patch, and bupropion. Acceptors (n=53) were defined as those accepting behavioral counseling and pharmacological treatment at some point during the 18-month study, whereas refusers (n=101) received only the expert system. The number of days to treatment acceptance was significantly predicted by stage of change, with those in preparation entering treatment more quickly than contemplators or precontemplators. In a logistic regression, the variables most strongly associated with accepting treatment were current use of psychiatric medication and perceived success for quitting. Severity of depressive symptoms, duration of depression history, and history of recurrent depression were not related to treatment acceptance. Findings have implications for the psychiatric assessment and treatment of smokers in clinical settings. Psychiatric medication may play a significant role in smoking cessation treatment acceptance by currently depressed smokers.

UR - http://www.scopus.com/inward/record.url?scp=20744452802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20744452802&partnerID=8YFLogxK

U2 - 10.1080/14622200500055368

DO - 10.1080/14622200500055368

M3 - Article

C2 - 16036278

AN - SCOPUS:20744452802

VL - 7

SP - 217

EP - 224

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 2

ER -